https://pcm-dev2.dana-farberblogs.com/clinical_trials/radiation-therapy-and-chemotherapy-in-treating-patients-with-stage-i-bladder-cancer/ 2016-04-25T20:24:45+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/carboplatin-and-bevacizumab-for-recurrent-ependymoma/ 2016-04-25T20:24:46+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-2-study-of-medi4736-in-patients-with-glioblastoma/ 2016-04-25T20:24:47+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/combination-chemotherapy-with-or-without-autologous-stem-cell-transplant-in-treating-patients-with-central-nervous-system-b-cell-lymphoma/ 2016-04-25T20:24:47+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-oral-ceritinib-in-patients-with-alk-positive-nsclc-metastatic-to-the-brain-andor-to-leptomeninges/ 2016-04-25T20:24:48+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/dose-escalated-photon-imrt-or-proton-beam-radiation-therapy-versus-standard-dose-radiation-therapy-and-temozolomide-in-treating-patients-with-newly-diagnosed-glioblastoma/ 2016-04-25T20:24:48+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/th-302-in-combination-with-bevacizumab-for-glioblastoma/ 2016-04-25T20:24:48+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/ph-i-personalized-neoantigen-cancer-vaccine-with-radiotherapy-for-patients-with-mgmt-unmethylated-newly-diagnosed-glioblastoma/ 2016-04-25T20:24:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/mri-guided-focused-ultrasound-feasibility-study-for-brain-tumors/ 2016-04-25T20:24:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-idh305-in-patients-with-advanced-malignancies-that-harbor-idh1r132-mutations/ 2016-04-25T20:24:50+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-pilot-study-to-evaluate-pbr-pet-in-brain-tumor-patients-treated-with-chemoradiation-or-immunotherapy/ 2016-04-25T20:24:50+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-i-dose-escalation-study-of-bkm120-with-radiation-therapy-and-temozolomide-in-patients-with-newly-diagnosed-glioblastoma/ 2016-04-25T20:24:50+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-orally-administered-ag-881-in-patients-with-advanced-solid-tumors-including-gliomas-with-an-idh1-andor-idh2-mutation/ 2016-04-25T20:24:51+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/vaccine-therapy-with-bevacizumab-versus-bevacizumab-alone-in-treating-patients-with-recurrent-glioblastoma-multiforme-that-can-be-removed-by-surgery/ 2016-04-25T20:24:53+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/trial-of-ponatinib-in-patients-with-bevacizumab-refractory-glioblastoma/ 2016-04-25T20:24:54+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-and-efficacy-of-inc280-and-buparlisib-bkm120-in-patients-with-recurrent-gliobastoma/ 2016-04-25T20:24:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/bevacizumab-with-or-without-radiation-therapy-in-treating-patients-with-recurrent-glioblastoma/ 2016-04-25T20:24:56+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/standard-or-comprehensive-radiation-therapy-in-treating-patients-with-early-stage-breast-cancer-previously-treated-with-chemotherapy-and-surgery/ 2016-04-25T20:24:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/olaparib-as-adjuvant-treatment-in-patients-with-germline-brca-mutated-high-risk-her2-negative-primary-breast-cancer/ 2016-04-25T20:24:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/t-dm1-vs-paclitaxeltrastuzumab-for-breast-atempt-trial/ 2016-04-25T20:25:00+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/fulvestrant-andor-anastrozole-in-treating-postmenopausal-patients-with-stage-ii-iii-breast-cancer-undergoing-surgery/ 2016-04-25T20:25:00+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/breast-conserving-surgery-and-radiation-therapy-in-patients-with-multiple-ipsilateral-breast-cancer/ 2016-04-25T20:25:01+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/t-dm1pertuzumab-in-pre-op-early-stage-her2-brca/ 2016-04-25T20:25:03+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/evaluating-mass-spectrometry-and-intraoperative-mri-in-the-advanced-multimodality-image-guided-operating-suite-amigo-in-breast-conserving-therapy/ 2016-04-25T20:25:04+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/paclitaxel-trastuzumab-pertuzumab-as-pre-op-for-inflammatory-brca/ 2016-04-25T20:25:04+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/naltrexone-rct-for-treatment-emergent-fatigue-in-patients-receiving-radiation-therapy-for-breast-cancer/ 2016-04-25T20:25:05+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/trastuzumab-emtansine-in-treating-older-patients-with-human-epidermal-growth-factor-receptor-2-positive-stage-i-iii-breast-cancer/ 2016-04-25T20:25:06+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/low-dose-tamoxifen-citrate-in-reducing-breast-cancer-risk-in-radiation-induced-cancer-survivors/ 2016-04-25T20:25:06+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cisplatin-vs-doxorubicincyclophosphamide-in-brca/ 2016-04-25T20:25:07+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cisplatin-rt-for-triple-negative-breast-cancer/ 2016-04-25T20:25:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ib-dose-escalation-trial-of-taselisib-gdc-0032-in-combination-with-anti-her2-therapies-in-participants-with-advanced-her2-breast-cancer/ 2016-04-25T20:25:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-palbociclib-in-combination-with-bazedoxifene-in-hormone-receptor-positive-breast-cancer/ 2016-04-25T20:25:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/the-incidence-of-adjacent-synchronous-ipsilateral-infiltrating-carcinoma-andor-dcis-in-patients-diagnosed-with-intraductal-papilloma-without-atypia-or-flat-epithelial-atypia-by-core-needle-biopsy/ 2016-04-25T20:25:10+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-pilot-study-of-acupuncture-for-chemotherapy-induced-peripheral-neuropathy-in-breast-cancer-patients/ 2016-04-25T20:25:10+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pregnancy-outcome-and-safety-of-interrupting-therapy-for-women-with-endocrine-responsive-breast-cancer/ 2016-04-25T20:25:11+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/doxorubicin-hydrochloride-and-cyclophosphamide-followed-by-paclitaxel-with-or-without-carboplatin-in-treating-patients-with-triple-negative-breast-cancer/ 2016-04-25T20:25:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-neratinib-plus-capecitabine-versus-lapatinib-plus-capecitabine-in-patients-with-her2-metastatic-breast-cancer-who-have-received-two-or-more-prior-her2-directed-regimens-in-the-metastatic-s/ 2016-04-25T20:25:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/mm-302-plus-trastuzumab-vs-chemotherapy-of-physicians-choice-plus-trastuzumab-in-her2-positive-locally-advancedmetastatic-breast-cancer-patients/ 2016-04-25T20:25:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/neratinib-in-metastatic-her2-non-amplified-but-her2-mutant-breast-cancer/ 2016-04-25T20:25:14+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/hki-272-for-her2-positive-breast-cancer-and-brain-metastases/ 2016-04-25T20:25:14+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cisplatin-vs-paclitaxel-for-triple-neg/ 2016-04-25T20:25:15+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-abemaciclib-ly2835219-in-participants-with-breast-cancer-non-small-cell-lung-cancer-or-melanoma-that-has-spread-to-the-brain/ 2016-04-25T20:25:15+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-to-assess-the-efficacy-and-safety-of-enzalutamide-with-trastuzumab-in-subjects-with-human-epidermal-growth-factor-receptor-2-positive-her2-androgen-receptor-positive-ar-and-estrogen-rec/ 2016-04-25T20:25:15+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-study-of-eribulin-mesylate-trastuzumab-and-pertuzumab-in-women-with-metastatic-unresectable-locally-advanced-or-locally-recurrent-her2-positive-breast-cancer/ 2016-04-25T20:25:17+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-ii-clinical-trial-of-pm01183-in-brca-12-associated-or-unselected-metastatic-breast-cancer/ 2016-04-25T20:25:17+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cabozantinib-trastuzumab-in-breast-cancer-patients-w-brain-metastases/ 2016-04-25T20:25:17+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/eribulin-in-her2-negative-metastatic-brca/ 2016-04-25T20:25:18+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cabozantinib-in-women-with-metastatic-hormone-receptor-positive-breast-cancer/ 2016-04-25T20:25:18+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-the-combination-of-kd019-and-trastuzumab-in-subjects-with-her2-positive-metastatic-breast-cancer/ 2016-04-25T20:25:19+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/intrathecal-trastuzumab-for-leptomeningeal-metastases-in-her2-breast-cancer/ 2016-04-25T20:25:20+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-lee011-with-fulvestrant-and-byl719-or-bkm120-in-advanced-breast-cancer/ 2016-04-25T20:25:20+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/byl719-and-letrozole-in-post-menopausal-patients-with-hormone-receptor-positive-metastatic-breast-cancer/ 2016-04-25T20:25:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-ly2835219-abemaciclib-in-combination-with-therapies-for-breast-cancer-that-has-spread/ 2016-04-25T20:25:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/defining-the-her2-positive-breast-cancer-kinome-response-to-trastuzumab-pertuzumab-combination-trastuzumab-pertuzumab-or-combination-trastuzumab-lapatinib/ 2016-04-25T20:25:22+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-safety-study-of-sgn-liv1a-in-breast-cancer-patients/ 2016-04-25T20:25:22+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pilot-study-of-zirconium-89-bevacizumab-positron-emission-tomography-for-imaging-angiogenesis-in-patients-with-inflammatory-breast-carcinoma-receiving-preoperative-chemotherapy/ 2016-04-25T20:25:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-pi3-kinase-inhibitor-gdc-0941-in-combination-with-paclitaxel-and-bevacizumab-in-patients-with-locally-recurrent-or-metastatic-breast-cancer/ 2016-04-25T20:25:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-atezolizumab-mpdl3280a-in-combination-with-nab-paclitaxel-compared-with-placebo-with-nab-paclitaxel-for-patients-with-previously-untreated-metastatic-triple-negative-breast-cancer-impass/ 2016-04-25T20:25:24+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-pembrolizumab-mk-3475-monotherapy-for-metastatic-triple-negative-breast-cancer-mk-3475-086keynote-086/ 2016-04-25T20:25:26+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/sandpiper-study-a-study-of-taselisib-fulvestrant-versus-placebo-fulvestrant-in-patients-with-advanced-or-metastatic-breast-cancer-who-have-disease-recurrence-or-progression-during-or-after-aromat/ 2016-04-25T20:25:26+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-dose-escalation-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-gdc-0032-in-combination-with-docetaxel-or-with-paclitaxel-in-patients-with-her2-negative-locally-recurrent-or-metast/ 2016-04-25T20:25:26+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/evaluation-of-biomarkers-associated-with-response-to-subsequent-therapies-in-subjects-with-her2-positive-metastatic-breast-cancer/ 2016-04-25T20:25:27+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/standard-genetic-counseling-with-or-without-a-decision-guide-in-improving-communication-between-mothers-undergoing-brca12-testing-and-their-minor-age-children/ 2016-04-25T20:25:28+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-srn-927-in-postmenopausal-women-with-locally-advanced-or-metastatic-estrogen-receptor-positive-breast-cancer/ 2016-04-25T20:25:28+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/prevention-strategy-for-pre-menopausal-women-at-high-risk-for-development-of-breast-cancer/ 2016-04-25T20:25:29+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/observational-us-study-assessing-outcomes-treatment-patterns-aes-qol-in-mf-ctcl-patients-and-treated-with-valchlor/ 2016-04-25T20:25:36+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/sorafenib-for-hepatocellular-cancer-with-chronic-hepatitis-c/ 2016-04-25T20:25:40+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/trial-of-eflornithine-plus-sulindac-in-patients-with-familial-adenomatous-polyposis-fap/ 2016-04-25T20:25:42+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/chemotherapy-alone-or-chemotherapy-plus-radiation-therapy-in-treating-patients-with-locally-advanced-rectal-cancer-undergoing-surgery/ 2016-04-25T20:25:43+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-trial-of-dasatinib-in-patients-with-isocitrate-dehydrogenase-idh-mutant-advanced-intrahepatic-cholangiocarcinoma/ 2016-04-25T20:25:44+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-trial-of-irinotecan-cetuximab-and-bevacizumab-compared-with-irinotecan-cetuximab-and-placebo-in-kras-wildtype-irinotecan-refractory-metastatic-colorectal-cancer/ 2016-04-25T20:25:45+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-nivolumab-and-nivolumab-plus-ipilimumab-in-recurrent-and-metastatic-colon-cancer-checkmate-142/ 2016-04-25T20:25:46+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-dkn-01-and-gemcitabinecisplatin-in-patients-with-carcinoma-to-primary-to-the-intra-or-extra-hepatic-biliary-system-or-gallbladder/ 2016-04-25T20:25:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-1-study-of-mgd007-in-relapsedrefractory-metastatic-colorectal-carcinoma/ 2016-04-25T20:25:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/brafmekegfr-inhibitor-combination-study-in-colorectal-cancer/ 2016-04-25T20:25:52+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/calcineurin-inhibitor-free-interventions-for-prevention-of-graft-versus-host-disease-bmt-ctn-1301/ 2016-04-25T20:25:53+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/an-open-label-phase-ii-trial-of-topical-sirolimus-for-the-treatment-of-refractory-oral-chronic-graft-versus-host-disease/ 2016-04-25T20:25:54+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/novel-approaches-for-graft-versus-host-disease-prevention-compared-to-contemporary-controls-bmt-ctn-1203/ 2016-04-25T20:25:54+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-trial-of-natalizumab-tysabri-plus-prednisone-for-initial-therapy-of-acute-graft-versus-host-disease-agvhd-of-the-gastrointestinal-tract/ 2016-04-25T20:25:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-pilot-study-of-alpha-1-antitrypsin-aat-in-steroid-refractory-acute-graft-vs-host-disease/ 2016-04-25T20:25:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-ii-trial-of-low-dose-interleukin-2-il-2-added-to-extra-corporeal-photopheresis-for-steroid-refractory-chronic-graft-versus-host-disease/ 2016-04-25T20:25:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-the-brutons-tyrosine-kinase-inhibitor-in-subjects-with-chronic-graft-versus-host-disease/ 2016-04-25T20:25:56+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-trial-of-lde225-for-steroid-refractory-chronic-gvhd-after-allogeneic-hsct/ 2016-04-25T20:25:56+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-i-study-of-abatacept-in-the-treatment-of-patients-with-steroid-refractory-chronic-graft-versus-host-disease-cgvhd/ 2016-04-25T20:25:57+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/image-guided-gynecologic-brachytherapy/ 2016-04-25T20:25:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/studying-the-physical-function-and-quality-of-life-before-and-after-surgery-in-patients-with-stage-i-cervical-cancer/ 2016-04-25T20:25:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-rucaparib-in-patients-with-platinum-sensitive-relapsed-high-grade-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer-ariel2/ 2016-04-25T20:26:02+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/effects-of-stm-434-alone-or-in-combination-with-liposomal-doxorubicin-in-patients-with-ovarian-cancer-or-other-advanced-solid-tumors/ 2016-04-25T20:26:04+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-of-bkm120olaparib-for-triple-negative-breast-cancer-or-high-grade-serous-ovarian-cancer/ 2016-04-25T20:26:04+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/first-in-human-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-imgn853-in-adults-with-ovarian-cancer-and-other-folr1-positive-solid-tumors/ 2016-04-25T20:26:05+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/sexual-therapy-and-rehabilitation-after-treatment-for-ovarian-cancer-start-oc-a-pilot-intervention/ 2016-04-25T20:26:05+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-azd1775-chemotherapy-versus-chemotherapy-in-patients-to-treat-ovarian-fallopian-tube-peritoneal-cancer/ 2016-04-25T20:26:06+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-niraparib-in-patients-with-ovarian-cancer-who-have-received-at-least-three-previous-chemotherapy-regimens/ 2016-04-25T20:26:07+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-to-evaluate-the-safety-and-pharmacology-of-dnib0600a-in-patients-with-ovarian-cancer/ 2016-04-25T20:26:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-ii-study-of-mln0128-in-metastatic-anaplastic-thyroid-cancer/ 2016-04-25T20:26:11+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/transoral-surgery-followed-by-low-dose-or-standard-dose-radiation-therapy-with-or-without-chemotherapy-in-treating-patients-with-hpv-positive-stage-iii-iva-oropharyngeal-cancer/ 2016-04-25T20:26:11+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cabozantinib-in-recurrentmetastatic-merkel-cell-carcinoma/ 2016-04-25T20:26:12+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-study-of-tipifarnib-in-advanced-cancers-with-hras-mutations/ 2016-04-25T20:26:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/mln0128-in-recurrentmetastatic-merkel-cell-carcinoma/ 2016-04-25T20:26:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-afatinib-and-postoperative-radiation-therapy-to-treat-head-and-neck-cancer/ 2016-04-25T20:26:14+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ib-study-of-bkm120-with-cisplatin-and-xrt-in-high-risk-locally-advanced-squamous-cell-cancer-of-head-and-neck/ 2016-04-25T20:26:14+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/image-guided-cryoablation-of-head-neck-and-spine-tumors/ 2016-04-25T20:26:15+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-study-of-medi4736-tremelimumab-and-medi4736-in-combination-w-tremelimumab-squamous-cell-carcinoma-of-the-head-and-neck/ 2016-04-25T20:26:16+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-study-of-medi4736-monotherapy-in-the-treatment-of-patients-with-recurrent-or-metastatic-scchn/ 2016-04-25T20:26:17+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/filgrastim-mobilized-stem-cells-for-transplantation-using-unrelated-donors/ 2016-04-25T20:26:18+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/gs-5806-in-hematopoietic-cell-transplant-recipients-with-respiratory-syncytial-virus-rsv-infection-of-the-lower-respiratory-tract/ 2016-04-25T20:26:19+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/gvax-vs-placebo-for-mdsaml-after-allo-hsct/ 2016-04-25T20:26:19+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/ipilimumab-in-treating-patients-with-relapsed-hematologic-malignancies-after-donor-stem-cell-transplantation/ 2016-04-25T20:26:20+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/mk-8228-letermovir-versus-placebo-in-the-prevention-of-clinically-significant-cytomegalovirus-cmv-infection-in-adult-cmv-seropositive-allogeneic-hematopoietic-stem-cell-transplant-recipients-mk/ 2016-04-25T20:26:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/allo-vs-hypomethylatingbest-supportive-care-in-mds-blood-and-marrow-transplant-clinical-trials-network-1102/ 2016-04-25T20:26:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/national-marrow-donor-program-long-term-donor-follow-up/ 2016-04-25T20:26:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/brentuximab-vedotin-plus-avd-in-limited-stage-hodgkin-lymphoma/ 2016-04-25T20:26:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/response-based-therapy-assessed-by-pet-scan-in-treating-patients-with-bulky-stage-i-and-stage-ii-classical-hodgkin-lymphoma/ 2016-04-25T20:26:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/everolimus-in-treating-patients-with-kidney-cancer-who-have-undergone-surgery/ 2016-04-25T20:26:25+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-2-study-of-b-701-in-treatment-of-locally-advanced-or-metastatic-urothelial-cell-carcinoma/ 2016-04-25T20:26:25+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-mocetinostat-in-patients-with-urothelial-carcinoma-having-inactivating-alterations-of-specific-genes/ 2016-04-25T20:26:26+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-ii-study-of-cyberknife-radiosurgery-for-renal-cell-carcinoma/ 2016-04-25T20:26:26+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-randomized-phase-2-trial-of-axitinib-and-trc105-versus-axitinib-alone-in-patients-with-advanced-or-metastatic-renal-cell-carcinoma/ 2016-04-25T20:26:26+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-hydroxychloroquine-and-aldesleukin-in-renal-cell-carcinoma-patients-rcc/ 2016-04-25T20:26:27+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pazopanib-and-everolimus-in-patients-with-advanced-solid-tumors-and-previously-treated-kidney-cancer/ 2016-04-25T20:26:28+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/exploratory-study-of-radium-223-and-vascular-endothelial-growth-factor-targeted-therapy-in-patients-with-metastatic-renal-cell-carcinoma-and-bone-metastases/ 2016-04-25T20:26:28+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-1-dose-escalation-trial-of-pt2385-tablets-in-patients-with-advanced-clear-cell-renal-cell-carcinoma/ 2016-04-25T20:26:29+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/an-expanded-access-study-of-mpdl3280a-in-patients-with-pd-l1-positive-locally-advanced-or-metastatic-urothelial-bladder-cancer-after-failure-with-platinum-containing-chemotherapy/ 2016-04-25T20:26:30+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-pembrolizumab-mk-3475-in-participants-with-advanced-urothelial-cancer-mk-3475-052keynote-52/ 2016-04-25T20:26:30+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-iii-open-label-randomized-study-of-atezolizumab-in-combination-with-bevacizumab-versus-sunitinib-in-patients-with-untreated-advance-renal-cell-carcinoma-immotion151/ 2016-04-25T20:26:30+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/double-cord-versus-haploidentical-blood-and-marrow-transplant-clinical-trials-network-1101/ 2016-04-25T20:26:32+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/an-open-label-study-of-quizartinib-monotherapy-vs-salvage-chemotherapy-in-acute-myeloid-leukemia-aml-subjects/ 2016-04-25T20:26:33+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/the-life-after-stopping-tyrosine-kinase-inhibitors-study-the-last-study/ 2016-04-25T20:26:34+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/reduced-intensity-double-umbilical-cord-blood-transplantation/ 2016-04-25T20:26:34+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-decitabine-dac-versus-azacitidine-aza-in-myelodysplastic-syndrome-mds/ 2016-04-25T20:26:35+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/braf-inhibitor-vemurafenib-in-patients-with-relapsed-or-refractory-hairy-cell-leukemia/ 2016-04-25T20:26:35+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-safety-and-tolerability-study-of-crenolanib-in-combination-with-chemotherapy-in-newly-diagnosed-acute-myeloid-leukemia-patients-with-flt3-mutations/ 2016-04-25T20:26:35+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/busulfanclofarabine-allogeneic-stem-cell-transplantation/ 2016-04-25T20:26:36+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-to-determine-safety-pharmacokinetics-and-efficacy-of-gmi-1271-in-combination-with-chemotherapy-in-aml/ 2016-04-25T20:26:37+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pyrimethamine-for-the-treatment-of-relapsed-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma/ 2016-04-25T20:26:37+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-iii-trial-of-the-muc1-inhibitor-go-203-2c-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia/ 2016-04-25T20:26:38+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/sl-401-in-patients-with-blastic-plasmacytoid-dendritic-cell-neoplasm-or-acute-myeloid-leukemia/ 2016-04-25T20:26:39+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-and-tolerability-study-of-oral-ns-018-in-patients-with-primary-myelofibrosis-mf-post-polycythemia-vera-mf-or-post-essential-thrombocythemia-mf/ 2016-04-25T20:26:39+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-dose-escalation-and-cohort-expansion-study-of-ten-010-in-patients-with-acute-myeloid-leukemia-and-myelodysplastic-syndrome/ 2016-04-25T20:26:40+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-sequential-two-stage-dose-escalation-study-to-evaluate-the-safety-and-efficacy-of-ruxolitinib/ 2016-04-25T20:26:40+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-safety-study-of-sgn-cd33a-in-aml-patients/ 2016-04-25T20:26:40+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-ibrutinib-obinutuzumab-in-patients-with-relapsed-or-refractory-chronic-lymphocytic-leukemia/ 2016-04-25T20:26:41+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-study-of-mln-9708-in-addition-to-chemotherapy-for-the-treatment-of-acute-lymphoblastic-leukemia-in-older-adults/ 2016-04-25T20:26:42+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-study-of-ag-221-in-subjects-with-advanced-hematologic-malignancies-with-an-idh2-mutation/ 2016-04-25T20:26:42+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-i-multicenter-open-label-study-of-oral-abl001-in-patients-with-chronic-myelogenous-leukemia-cml-or-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-ph-all/ 2016-04-25T20:26:43+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-1b-acute-myelogenous-leukemia-aml-study-with-abt-199-decitabine-or-azacitidine-chemo-combo/ 2016-04-25T20:26:44+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-orally-administered-ag-120-in-subjects-with-advanced-hematologic-malignancies-with-an-idh1-mutation/ 2016-04-25T20:26:44+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-1-study-to-evaluate-medi4736/ 2016-04-25T20:26:45+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-dose-escalation-of-bay1143572-in-subjects-with-acute-leukemia/ 2016-04-25T20:26:45+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/sgi-110-in-adults-with-untreated-acute-myeloid-leukemia-aml-not-considered-candidates-for-intensive-remission-induction/ 2016-04-25T20:26:45+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/sorafenib-mfolfox-for-hepatocellular-carcinoma/ 2016-04-25T20:26:47+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-tivantinib-in-subjects-with-inoperable-hepatocellular-carcinoma-who-have-been-treated-with-one-prior-therapy/ 2016-04-25T20:26:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/erlotinib-hydrochloride-in-treating-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-that-has-been-completely-removed-by-surgery-an-alchemist-treatment-trial/ 2016-04-25T20:26:51+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/crizotinib-in-treating-patients-with-stage-ib-iiia-non-small-cell-lung-cancer-that-has-been-removed-by-surgery-and-alk-fusion-mutations-an-alchemist-treatment-trial/ 2016-04-25T20:26:51+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/three-different-radiation-therapy-regimens-in-treating-patients-with-limited-stage-small-cell-lung-cancer-receiving-cisplatin-and-etoposide/ 2016-04-25T20:26:51+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/window-of-opportunity-study-of-vs-6063-defactinib-in-participants-with-surgical-resectable-malignant-pleural-mesothelioma/ 2016-04-25T20:26:52+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-2-study-of-auy922-in-nsclc-patients-with-exon-20-insertion-mutations-in-egfr/ 2016-04-25T20:26:52+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cabozantinib-in-advanced-solid-malignancies/ 2016-04-25T20:26:52+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/sunitinib-in-never-smokers-with-lung-adenocarcinoma/ 2016-04-25T20:26:53+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/afatinib-with-ct-and-rt-for-egfr-mutant-nsclc/ 2016-04-25T20:26:53+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-olaparib-and-temozolomide-in-patients-with-recurrent-small-cell-lung-cancer-following-failure-of-prior-chemotherapy/ 2016-04-25T20:26:54+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-pf-06463922-an-alkros1-inhibitor-in-patients-with-advanced-non-small-cell-lung-cancer-with-specific-molecular-alterations/ 2016-04-25T20:26:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-12a-study-of-oral-rxdx-101-in-adult-patients-with-locally-advanced-or-metastatic-cancer-study-targeting-alk-ros1-or-trkabc/ 2016-04-25T20:26:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-dose-escalation-study-of-asp8273-in-subjects-with-non-small-cell-lung-cancer-nsclc-who-have-epidermal-growth-factor-receptor-egfr-mutations/ 2016-04-25T20:26:56+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-first-in-human-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ds-6051b/ 2016-04-25T20:26:56+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/real-time-image-guided-lymphatic-mapping-and-nodal-targeting-in-lung-cancer/ 2016-04-25T20:26:56+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-to-optimize-care-for-lung-cancer-patients-undergoing-video-assisted-thoracoscopic-surgery-vats/ 2016-04-25T20:26:57+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-mpdl3280a-in-combination-with-incb024360-in-subjects-with-previously-treated-stage-iiib-or-stage-iv-non-small-cell-lung-cancer/ 2016-04-25T20:26:57+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/azd9291-in-combination-with-ascending-doses-of-novel-therapeutics/ 2016-04-25T20:26:57+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/expanded-access-study-of-alectinib-for-patients-with-alk-rearranged-non-small-cell-lung-cancer-previously-treated-with-crizotinib/ 2016-04-25T20:26:58+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-1b-study-of-medi4736-in-combination-with-tremelimumab-in-subjects-with-advanced-non-small-cell-lung-cancer/ 2016-04-25T20:26:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-1b-study-of-mpdl3280a-an-engineered-anti-pdl1-antibody-in-combination-with-tarceva-in-patients-with-non-small-cell-lung-cancer/ 2016-04-25T20:26:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/efficacy-and-safety-of-momelotinib-and-momelotinib-combined-with-trametinib-in-adults-with-metastatic-kras-mutated-non-small-cell-lung-cancer-nsclc-who-have-failed-platinum-based-chemotherapy-preced/ 2016-04-25T20:27:00+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-global-study-to-assess-the-effects-of-medi4736-following-concurrent-chemoradiation-in-patients-with-stage-iii-unresectable-non-small-cell-lung-cancer/ 2016-04-25T20:27:00+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-ii-study-of-ibrutinib-plus-fcr-in-previously-untreated-younger-patients-with-chronic-lymphocytic-leukemia/ 2016-04-25T20:27:02+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-lenalidomide-for-adult-histiocyte-disorders/ 2016-04-25T20:27:02+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cellular-immunotherapy-treatment-antigen-directed-for-ebv-lymphoma/ 2016-04-25T20:27:03+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pembrolizumab-after-asct-for-hodgkin-lymphoma-and-dlbcl/ 2016-04-25T20:27:04+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/carfilzomib-plus-belinostat-in-relapsedrefractory-nhl/ 2016-04-25T20:27:07+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-anti-lag-3-in-cll-hl-and-nhl/ 2016-04-25T20:27:07+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-alrn-6924-in-patients-with-advanced-solid-tumors-or-lymphomas/ 2016-04-25T20:27:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-2-open-label-study-of-the-efficacy-and-safety-of-abt-199-gdc-0199-in-chronic-lymphocytic-leukemia-cll-subjects-with-relapse-or-refractory-to-b-cell-receptor-signaling-pathway-inhibitor-the/ 2016-04-25T20:27:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-iib-safety-and-efficacy-study-of-the-pi3k-delta-inhibitor-tgr-1202-and-ibrutinib-in-patients-with-cll-or-mcl/ 2016-04-25T20:27:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/acp-196-in-combination-with-pembrolizumab-for-treatment-of-b-cell-malignancies/ 2016-04-25T20:27:09+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-trial-of-mk-3475-in-participants-with-blood-cancers/ 2016-04-25T20:27:09+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-3-extension-study-of-ipi-145-and-ofatumumab-in-patients-with-cllsll-previously-enrolled-in-study-ipi-145-07/ 2016-04-25T20:27:10+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/ipilimumab-with-or-without-bevacizumab-in-treating-patients-with-stage-iii-iv-melanoma-that-cannot-be-removed-by-surgery/ 2016-04-25T20:27:12+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cabozantinib-s-malate-compared-with-temozolomide-or-dacarbazine-in-treating-patients-with-melanoma-of-the-eye/ 2016-04-25T20:27:12+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-i-study-with-a-personalized-neoantigen-cancer-vaccine-in-melanoma/ 2016-04-25T20:27:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-multi-center-phase-2-open-label-study-to-evaluate-safety-and-efficacy-in-subjects-with-melanoma-metastatic-to-the-brain-treated-with-nivolumab-in-combination-with-ipilimumab-followed-by-nivolumab-mo/ 2016-04-25T20:27:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/rta-408-capsules-in-patients-with-melanoma-reveal/ 2016-04-25T20:27:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-clinical-trial-of-tremelimumab-plus-medi3617-in-patients-with-unresectable-stage-iii-or-stage-iv-melanoma/ 2016-04-25T20:27:14+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/ipilimumab-with-or-without-dabrafenib-andor-trametinib-in-treating-patients-with-melanoma-that-is-metastatic-or-cannot-be-removed-by-surgery/ 2016-04-25T20:27:14+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-the-safety-and-pharmacology-of-mpdl3280a-administered-in-combination-with-vemurafenib-zelboraf-in-patients-with-previously-untreated-brafv600-mutation-positive-metastatic-melanoma/ 2016-04-25T20:27:15+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/dendritic-cell-activating-scaffold-in-melanoma/ 2016-04-25T20:27:15+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-the-safety-and-pharmacokinetics-of-mpdl3280a-administered-intravenously-as-a-single-agent-to-patients-with-locally-advanced-or-metastatic-solid-tumors/ 2016-04-25T20:27:16+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/randomized-trial-of-lenalidomide-bortezomib-dexamethasone-vs-high-dose-treatment-with-sct-in-mm-patients-up-to-age-65/ 2016-04-25T20:27:18+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-and-efficacy-of-pomalidomide-bortezomib-and-low-dose-dexamethasone-in-subjects-with-relapsed-or-refractory-multiple-myeloma/ 2016-04-25T20:27:19+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-study-of-efficacy-and-safety-of-lenalidomide-subcutaneous-bortezomib-and-dexamethasone-therapy-for-newly-diagnosed-multiple-myeloma/ 2016-04-25T20:27:19+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/trial-of-combination-of-elotuzumab-and-lenalidomide-dexamethasone-in-high-risk-smoldering-multiple-myeloma/ 2016-04-25T20:27:19+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-and-efficacy-of-melflufen-and-dexamethasone-in-relapsed-andor-relapsed-refractory-multiple-myeloma-patients/ 2016-04-25T20:27:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-bortezomiblenalidomidedexamethasone-elotuzumab-in-newly-diagnosed-mm/ 2016-04-25T20:27:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-i-study-of-panobinostatlenalidomidebortezomibdex-for-relapsed-and-relapsedrefractory-multiple-myeloma/ 2016-04-25T20:27:22+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-chimeric-antigen-receptor-modified-t-cells-targeting-nkg2d-ligands/ 2016-04-25T20:27:22+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/combination-study-of-pomalidomide-marizomib-and-dexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2016-04-25T20:27:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-acy-241-alone-and-in-combination-with-pomalidomide-and-dexamethasone-in-multiple-myeloma/ 2016-04-25T20:27:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/ace-011-with-lenalidomidedexamethasone-for-relapsedrefractory-multiple-myeloma/ 2016-04-25T20:27:24+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/effect-of-eltrombopag-plus-granulocyte-colony-stimulating-factor-g-csf-on-human-cd34-cell-mobilization-in-multiple-myeloma-patients-undergoing-autologous-stem-cell-transplant-asct/ 2016-04-25T20:27:24+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/genomic-and-psychosocial-effects-of-the-3rp-on-patients-with-mgus-and-smoldering-multiple-myeloma/ 2016-04-25T20:27:25+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/dose-escalation-study-to-investigate-the-safety-pharmacokinetics-pharmacodynamics-immunogenicity-and-clinical-activity-of-gsk2857916/ 2016-04-25T20:27:25+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-2-study-to-evaluate-the-oral-combination-of-ixazomib-mln9708-with-cyclophosphamide-and-dexamethasone-in-patients-with-newly-diagnosed-or-relapsed-andor-refractory-multiple-myeloma/ 2016-04-25T20:27:26+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cabozantinib-in-advanced-pancreatic-neuroendocrine-and-carcinoid-tumors/ 2016-04-25T20:27:28+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/echelon-2-a-comparison-of-brentuximab-vedotin-and-chp-with-standard-of-care-chop-in-the-treatment-of-patients-with-cd30-positive-mature-t-cell-lymphomas/ 2016-04-25T20:27:29+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-2-clinical-trial-of-rituxan-and-b-glucan-pgg-in-relapsed-indolent-non-hodgkin-lymphoma/ 2016-04-25T20:27:29+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-study-of-dose-adjusted-epoch-rituximab-in-adults-with-untreated-burkitt-lymphoma-and-c-myc-diffuse-large-b-cell-lymphoma/ 2016-04-25T20:27:30+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cancer-associated-thrombosis-and-isoquercetin-cat-iq/ 2016-04-25T20:27:31+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/efficacy-and-safety-of-the-combination-therapy-of-dabrafenib-and-trametinib-in-subjects-with-braf-v600e-mutated-rare-cancers/ 2016-04-25T20:27:32+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/harnessing-the-effect-of-an-open-label-placebo-on-fatigue-in-cancer-survivors/ 2016-04-25T20:27:32+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/aspirin-intervention-for-the-reduction-of-colorectal-cancer-risk/ 2016-04-25T20:27:32+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pharmacokinetic-safety-and-tolerability-study-of-recombinant-von-willebrand-factor-recombinant-factor-viii-complex-in-type-3-von-willebrand-disease/ 2016-04-25T20:27:34+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/m402-in-combination-with-nab-paclitaxel-and-gemcitabine-in-pancreatic-cancer/ 2016-04-25T20:27:35+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-gemcitabine-and-nab-paclitaxel-with-or-without-npc-1c-to-treat-patients-with-pancreatic-cancer/ 2016-04-25T20:27:35+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/gemcitabine-and-nab-paclitaxel-combined-with-momelotinib-in-participants-with-previously-untreated-metastatic-pancreatic-ductal-adenocarcinoma/ 2016-04-25T20:27:35+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/lde225-with-fluorouracil-leucovorin-oxaliplatin-and-irinotecan-for-untreated-advanced-pancreatic-cancer/ 2016-04-25T20:27:36+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-evaluating-the-safety-and-pharmacokinetics-of-dmuc4064a-in-patients-with-platinum-resistant-ovarian-cancer-or-unresectable-pancreatic-cancer/ 2016-04-25T20:27:36+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/enzalutamide-in-first-line-androgen-deprivation-therapy-for-metastatic-prostate-cancer/ 2016-04-25T20:27:38+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/enzalutamide-in-androgen-deprivation-therapy-with-radiation-therapy-for-high-risk-clinically-localised-prostate-cancer/ 2016-04-25T20:27:38+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-galeterone-compared-to-enzalutamide-in-men-expressing-androgen-receptor-splice-variant-7-mrna-ar-v7-metastatic-crpc/ 2016-04-25T20:27:38+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/s1216-phase-iii-adttak-700-vs-adtbicalutamide-for-metastatic-prostate-cancer/ 2016-04-25T20:27:39+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-clinical-trial-of-abiraterone-acetate-without-exogenous-glucocorticoids-in-men-with-castration-resistant-prostate-cancer-with-correlative-assessment-of-hormone-intermediates/ 2016-04-25T20:27:39+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/enzalutamideleuprolide-abirateronepred-in-prostate/ 2016-04-25T20:27:40+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/enzalutamide-external-beam-rt-for-prostate/ 2016-04-25T20:27:40+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cyt107-after-vaccine-treatment-provenge-in-patients-with-metastatic-hormone-resistant-prostate-cancer/ 2016-04-25T20:27:40+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-trial-of-enzalutamide-for-castrate-resistant-prostate-cancer-with-correlative-assessment-of-androgen-receptor-signaling/ 2016-04-25T20:27:41+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-selective-androgen-receptor-modulator-for-symptom-management-in-prostate-cancer/ 2016-04-25T20:27:41+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/early-changes-in-multiparametric-mri-in-prostate-cancer/ 2016-04-25T20:27:42+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/focal-mr-guided-focused-ultrasound-treatment-of-localized-low-risk-prostate-cancer/ 2016-04-25T20:27:42+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/incorporating-mr-imaging-into-prostate-radiotherapy-treatment-planning/ 2016-04-25T20:27:42+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/observational-study-for-the-evaluation-of-long-term-safety-of-radium-223-used-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer/ 2016-04-25T20:27:43+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/proton-beam-radiation-therapy-for-central-nervous-system-cns-germ-cell-tumors/ 2016-04-25T20:27:44+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/short-course-radiation-therapy-with-proton-or-photon-beam-capecitabine-and-hydroxychloroquine-for-resectable-pancreatic-cancer/ 2016-04-25T20:27:44+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/midostaurin-pkc412-for-locally-advanced-rectal-cancer/ 2016-04-25T20:27:44+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-evaluating-a-stereotactic-boosttreatment-for-recurrent-or-metastatic-cancer-of-the-head-and-neck/ 2016-04-25T20:27:45+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-doxorubicin-plus-olaratumab-ly3012207-in-participants-with-advanced-or-metastatic-soft-tissue-sarcoma/ 2016-04-25T20:27:46+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/surgery-with-or-without-radiation-therapy-in-treating-patients-with-previously-untreated-nonmetastatic-retroperitoneal-soft-tissue-sarcoma/ 2016-04-25T20:27:46+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/plx3397-phase-3-study-for-pigmented-villonodular-synovitis-pvns-or-giant-cell-tumor-of-the-tendon-sheath-gct-ts/ 2016-04-25T20:27:47+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-mocetinostat-and-gemcitabine-in-patients-with-metastatic-leiomyosarcoma/ 2016-04-25T20:27:48+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-blanket-protocol-to-study-oral-regorafenib-in-patients-with-refractory-liposarcoma-osteogenic-sarcoma-and-ewingewing-like-sarcomas/ 2016-04-25T20:27:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/dose-reduction-of-preoperative-radiotherapy-in-myxoid-liposarcomas/ 2016-04-25T20:27:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-pazopanib-in-the-treatment-of-osteosarcoma-metastatic-to-the-lung/ 2016-04-25T20:27:50+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/proton-or-photon-rt-for-retroperitoneal-sarcomas/ 2016-04-25T20:27:50+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-study-of-olaprib-and-temozolomide-for-ewings-sarcoma/ 2016-04-25T20:27:50+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-non-randomized-open-label-single-center-phase-ib-study-of-short-cycles-of-sunitinib-alternating-with-regorafenib-in-patients-with-metastatic-andor-unresectable-gastrointestinal-stromal-tumors-gi/ 2016-04-25T20:27:51+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-i-dose-escalation-study-of-cgm097-in-adult-patients-with-selected-advanced-solid-tumors/ 2016-04-25T20:27:51+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-1-study-evaluating-amg-232-in-advanced-solid-tumors-or-multiple-myeloma/ 2016-04-25T20:27:52+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-1-study-of-blu-285-in-patients-with-gastrointestinal-stromal-tumors-gist-and-other-relapsed-and-refractory-solid-tumors/ 2016-04-25T20:27:52+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/an-open-label-phase-2-study-of-neratinib-in-patients-with-solid-tumors-with-somatic-human-epidermal-growth-factor-receptor-egfr-her2-her3-mutations-or-egfr-gene-amplification/ 2016-04-25T20:27:54+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/palbociclib-pd-0325901-for-nsclc-and-solid-tumors/ 2016-04-25T20:27:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-12-open-label-study-of-nivolumab-monotherapy-or-nivolumab-combined-with-ipilimumab-in-subjects-with-advanced-or-metastatic-solid-tumors/ 2016-04-25T20:27:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-12-dose-escalation-safety-pk-pd-study-of-bvd-523-an-erk-12-inhibitor-in-patients-with-advanced-malignancies/ 2016-04-25T20:27:55+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-mga271-in-refractory-cancer/ 2016-04-25T20:27:56+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-dose-escalation-of-oral-bay1161909-in-combination-with-intravenous-paclitaxel/ 2016-04-25T20:27:57+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-pf-05212384-in-combination-with-other-anti-tumor-agents/ 2016-04-25T20:27:57+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-pharmacologic-study-of-cyc065-a-cyclin-dependent-kinase-inhibitor-in-patients-with-advanced-cancers/ 2016-04-25T20:27:57+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-two-part-multicenter-open-label-study-of-ten-010-given-subcutaneously/ 2016-04-25T20:27:58+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-1-safety-study-of-intradermal-id-lv305-in-patients-with-locally-advanced-relapsed-or-metastatic-cancer-expressing-ny-eso-1/ 2016-04-25T20:27:58+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-nivolumab-with-nab-paclitaxel-plus-or-minus-gemcitabine-in-pancreatic-cancer-nab-paclitaxel-carboplatin-in-stage-iiibiv-non-small-cell-lung-cancer-or-nab-paclitaxel-in-recurrent-me/ 2016-04-25T20:27:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-oral-sapacitabine-and-oral-seliciclib-in-patients-with-advanced-solid-tumors/ 2016-04-25T20:27:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/veliparib-and-dinaciclib-with-or-without-carboplatin-in-treating-patients-with-advanced-solid-tumors/ 2016-04-25T20:27:59+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/mln0128-and-bevacizumab-in-treating-patients-with-recurrent-glioblastoma-or-advanced-solid-tumors/ 2016-04-25T20:28:00+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-i-study-of-an-anti-kir-antibody-in-combination-with-an-anti-pd1-antibody-in-patients-with-advanced-solid-tumors/ 2016-04-25T20:28:00+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-oral-pf-02341066-a-c-methepatocyte-growth-factor-tyrosine-kinase-inhibitor-in-patients-with-advanced-cancer/ 2016-04-25T20:28:00+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-oral-mgcd265-administered-without-interruption-to-subjects-with-advanced-malignancies/ 2016-04-25T20:28:01+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-pf-06647263-in-patients-with-advanced-solid-tumors/ 2016-04-25T20:28:02+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-the-glutaminase-inhibitor-cb-839-in-solid-tumors/ 2016-04-25T20:28:02+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-ly3009120-in-participants-with-advanced-cancer-or-cancer-that-has-spread-to-other-parts-of-their-body/ 2016-04-25T20:28:02+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/ptc596-in-patients-with-advanced-solid-tumors/ 2016-04-25T20:28:03+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/debio-1347-101-phase-i-trial-in-advanced-solid-tumours-with-fibroblast-growth-factor-receptor-fgfr-alterations/ 2016-04-25T20:28:04+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pembrolizumab-and-ziv-aflibercept-in-treating-patients-with-advanced-solid-tumors/ 2016-04-25T20:28:04+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-anti-lag-3-with-and-without-anti-pd-1-in-the-treatment-of-solid-tumors/ 2016-04-25T20:28:05+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-evaluating-the-safety-of-escalating-doses-of-dlye5953a-in-patients-with-refractory-solid-tumors/ 2016-04-25T20:28:06+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-the-safety-tolerability-and-effects-of-cobimetinib-and-gdc-0994-in-patients-with-locally-advanced-or-metastatic-solid-tumors/ 2016-04-25T20:28:07+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-gdc-0575-alone-and-in-combination-with-gemcitabine-in-patients-with-refractory-solid-tumors-or-lymphoma/ 2016-04-25T20:28:07+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-1-study-to-evaluate-medi4736-in-combination-with-tremelimumab/ 2016-04-25T20:28:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/open-label-phase-i-dose-escalation-study-with-bay1143572-in-patients-with-advanced-cancer/ 2016-04-25T20:28:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/open-label-treatment-extension-study-with-sar245408-or-sar245409-as-a-monotherapy-or-as-a-combination-regimen/ 2016-04-25T20:28:08+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-orally-administered-ag-120-in-subjects-with-advanced-solid-tumors-including-glioma-with-an-idh1-mutation/ 2016-04-25T20:28:09+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-ro6958688-in-patients-with-locally-advanced-andor-metastatic-solid-tumors/ 2016-04-25T20:28:09+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-dose-escalation-study-evaluating-the-safety-and-tolerability-of-gdc-0032-in-patients-with-locally-advanced-or-metastatic-solid-tumors/ 2016-04-25T20:28:10+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-i-open-label-study-of-moxr0916-in-patients-with-locally-advanced-or-metastatic-solid-tumors/ 2016-04-25T20:28:10+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-1b-study-of-mpdl3280a-an-engineered-anti-pdl1-antibody-in-combination-with-cobimetinib-in-patients-with-locally-advanced-or-metastatic-solid-tumors/ 2016-04-25T20:28:10+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-ro5509554-and-mpdl3280a-administered-in-combination-in-patients-with-advanced-solid-tumors/ 2016-04-25T20:28:11+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-12-study-to-evaluate-medi4736/ 2016-04-25T20:28:11+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-and-efficacy-of-fgf401-in-patients-with-solid-malignancies/ 2016-04-25T20:28:12+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-ly2875358-in-combination-with-ramucirumab-ly3009806-in-participants-with-advanced-cancer/ 2016-04-25T20:28:13+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/trial-of-ixazomib-dexamethasone-and-rituximab-in-patients-with-untreated-waldenstroms-macroglobulinemia/ 2016-04-25T20:28:15+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-comparing-two-carboplatin-containing-regimens-for-children-and-young-adults-with-previously-untreated-low-grade-glioma/ 2016-04-25T20:28:17+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/maintenance-chemotherapy-or-observation-following-induction-chemotherapy-and-radiation-therapy-in-treating-younger-patients-with-newly-diagnosed-ependymoma/ 2016-04-25T20:28:17+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/cabozantinib-for-plexiform-neurofibromas-pn-in-subjects-with-nf1-16-years/ 2016-04-25T20:28:18+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/modafinil-in-treating-children-with-memory-and-attention-problems-caused-by-cancer-treatment-for-a-brain-tumor/ 2016-04-25T20:28:18+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/proton-radiotherapy-for-pediatric-brain-tumors-requiring-partial-brain-irradiation/ 2016-04-25T20:28:18+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-assessing-the-feasibility-of-a-surgery-and-chemotherapy-only-in-children-with-wnt-positive-medulloblastoma/ 2016-04-25T20:28:19+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/collecting-and-storing-blood-and-brain-tumor-tissue-samples-from-children-with-brain-tumors/ 2016-04-25T20:28:19+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pnoc-001-phase-ii-study-of-everolimus-for-recurrent-or-progressive-low-grade-gliomas-in-children/ 2016-04-25T20:28:20+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/neuropsychological-and-behavioral-testing-in-young-patients-with-cancer/ 2016-04-25T20:28:20+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/peg-interferon-alfa-2b-in-treating-young-patients-with-unresectable-plexiform-neurofibromas-associated-with-neurofibromatosis-type-1/ 2016-04-25T20:28:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/metronomic-and-targeted-anti-angiogenesis-therapy-for-children-with-recurrentprogressive-medulloblastoma/ 2016-04-25T20:28:21+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/evaluation-of-the-duration-of-therapy-for-thrombosis-in-children/ 2016-04-25T20:28:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-ii-trial-of-regadenoson-in-sickle-cell-anemia/ 2016-04-25T20:28:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/human-cl-rhfviii-in-previously-untreated-patients/ 2016-04-25T20:28:23+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/icon1-treatment-decisions-and-outcomes-in-pediatric-refractory-itp/ 2016-04-25T20:28:25+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-study-of-gene-modified-donor-t-cells-following-tcr-alpha-beta-depleted-stem-cell-transplant/ 2016-04-25T20:28:25+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/pyruvate-kinase-deficiency-natural-history-study/ 2016-04-25T20:28:26+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/therapeutic-use-of-the-amino-acid-leucine-in-the-treatment-of-transfusion-dependent-diamond-blackfan-anemia-patients/ 2016-04-25T20:28:27+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/safety-and-pharmacokinetic-study-of-escalating-doses-of-sp-420-an-iron-chelator-in-patients-with-%ce%b2-thalassemia/ 2016-04-25T20:28:28+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-1-pediatric-pkpd-study/ 2016-04-25T20:28:28+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/web-based-application-for-the-population-pharmacokinetic-service-phase-1-hemophilia/ 2016-04-25T20:28:28+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-of-prasugrel-in-pediatric-participants-with-sickle-cell-disease-scd/ 2016-04-25T20:28:29+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-phase-23-study-of-the-efficacy-and-safety-of-hematopoietic-stem-cells-transduced-with-lenti-d-lentiviral-vector-for-the-treatment-of-childhood-cerebral-adrenoleukodystrophy-ccald/ 2016-04-25T20:28:30+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/abatacept-as-gvhd-prophylaxis-phase-2/ 2016-04-25T20:28:31+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/a-study-to-investigate-the-safety-and-efficacy-of-an-anti-ifn%ce%b3-mab-in-children-affected-by-primary-haemophagocytic-lymphohistiocytosis/ 2016-04-25T20:28:33+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-ii-study-of-clofarabine-in-patients-with-recurrent-or-refractory-langerhans-cell-histiocytosis/ 2016-04-25T20:28:34+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/donor-umbilical-cord-blood-transplant-with-or-without-ex-vivo-expanded-cord-blood-progenitor-cells-in-treating-patients-with-acute-myeloid-leukemia-acute-lymphoblastic-leukemia-chronic-myelogenous-l/ 2016-04-25T20:28:37+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/different-therapies-in-treating-infants-with-newly-diagnosed-acute-leukemia/ 2016-04-25T20:28:39+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/use-feasibility-of-the-ithermonitor-in-pediatrics-patients-on-myelosuppresive-therapies/ 2016-04-25T20:28:40+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/brentuximab-vedotin-or-crizotinib-and-combination-chemotherapy-in-treating-patients-with-newly-diagnosed-stage-ii-iv-anaplastic-large-cell-lymphoma/ 2016-04-25T20:28:41+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/trial-of-a-single-prohema-modulated-cb-unit-as-part-of-a-double-cb-transplant-in-patients-with-hematologic-malignancies/ 2016-04-25T20:28:41+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/131i-mibg-alone-vs-131i-mibg-with-vincristine-and-irinotecan-vs131i-mibg-with-vorinistat/ 2016-04-25T20:28:42+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/phase-i-study-of-ldk378-in-pediatric-malignancies-with-a-genetic-alteration-in-anaplastic-lymphoma-kinase-alk/ 2016-04-25T20:28:42+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/lenalidomide-and-dinutuximab-with-or-without-isotretinoin-in-treating-younger-patients-with-refractory-or-recurrent-neuroblastoma/ 2016-04-25T20:28:43+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/n2012-01-phase-1-study-of-difluoromethylornithine-dfmo-and-celecoxib-with-cyclophosphamidetopotecan/ 2016-04-25T20:28:43+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/biomarkers-in-tumor-tissue-samples-from-patients-with-newly-diagnosed-neuroblastoma-or-ganglioneuroblastoma/ 2016-04-25T20:28:44+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/proton-rt-for-the-treatment-of-pediatric-rhabdomyosarcoma/ 2016-04-25T20:28:45+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/sunitinib-or-cediranib-for-alveolar-soft-part-sarcoma/ 2016-04-25T20:28:46+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/proton-radiation-for-the-treatment-of-pediatric-bone-and-non-rhabdomyosarcoma-soft-tissue-sarcomas/ 2016-04-25T20:28:46+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/combination-chemotherapy-with-or-without-ganitumab-in-treating-patients-with-newly-diagnosed-metastatic-ewing-sarcoma/ 2016-04-25T20:28:47+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/collecting-and-storing-biological-samples-from-patients-with-ewing-sarcoma/ 2016-04-25T20:28:47+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/collecting-and-storing-malignant-borderline-malignant-neoplasms-and-related-samples-from-young-patients-with-cancer/ 2016-04-25T20:28:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/the-icat2-gain-consortium-study/ 2016-04-25T20:28:49+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/intra-arterial-melphalan-in-treating-younger-patients-with-unilateral-retinoblastoma/ 2016-04-25T20:28:50+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/the-study-to-determine-safety-tolerability-and-pharmacokinetics-of-oral-dabrafenib-in-pediatric-subjects/ 2016-04-25T20:28:50+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-to-investigate-safety-pharmacokinetic-pk-pharmacodynamic-pd-and-clinical-activity-of-trametinib-in-subjects-with-cancer-or-plexiform-neurofibromas-and-trametinib-in-combination-with-dabraf/ 2016-04-25T20:28:51+00:00 https://pcm-dev2.dana-farberblogs.com/clinical_trials/study-of-kidney-tumors-in-younger-patients/ 2016-04-25T20:28:52+00:00